Hideharu Abe

2.2k total citations
69 papers, 1.7k citations indexed

About

Hideharu Abe is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, Hideharu Abe has authored 69 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Nephrology, 31 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Hideharu Abe's work include Chronic Kidney Disease and Diabetes (26 papers), Renal Diseases and Glomerulopathies (19 papers) and TGF-β signaling in diseases (12 papers). Hideharu Abe is often cited by papers focused on Chronic Kidney Disease and Diabetes (26 papers), Renal Diseases and Glomerulopathies (19 papers) and TGF-β signaling in diseases (12 papers). Hideharu Abe collaborates with scholars based in Japan, United States and United Kingdom. Hideharu Abe's co-authors include Toshio Doi, Kojiro Nagai, Toru Kita, Takeshi Matsubara, Hidenori Arai, Noriyuki Iehara, Toshikazu Takahashi, Atsushi Fukatsu, Seiji Kishi and Tatsuya Tominaga and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Hideharu Abe

67 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideharu Abe Japan 21 640 578 443 175 169 69 1.7k
Marinka A.H. Bakker Netherlands 26 861 1.3× 640 1.1× 333 0.8× 141 0.8× 124 0.7× 45 2.1k
Julia Lichtnekert Germany 23 661 1.0× 501 0.9× 813 1.8× 177 1.0× 51 0.3× 34 1.8k
Santhosh V. Kumar Germany 21 900 1.4× 446 0.8× 856 1.9× 176 1.0× 96 0.6× 35 2.0k
Murthy N. Darisipudi Germany 16 1.0k 1.6× 542 0.9× 984 2.2× 183 1.0× 125 0.7× 24 2.1k
Justin Chun Canada 17 1.1k 1.8× 507 0.9× 361 0.8× 220 1.3× 71 0.4× 35 1.7k
Ian R. Witherden United Kingdom 12 400 0.6× 446 0.8× 237 0.5× 88 0.5× 81 0.5× 13 1.2k
Jean‐Michel Goujon France 31 846 1.3× 659 1.1× 505 1.1× 529 3.0× 242 1.4× 83 2.6k
Ko‐Jen Li Taiwan 20 339 0.5× 140 0.2× 385 0.9× 101 0.6× 113 0.7× 78 1.2k
Jyaysi Desai Germany 20 897 1.4× 483 0.8× 943 2.1× 159 0.9× 126 0.7× 24 2.1k
An‐Hang Yang Taiwan 23 491 0.8× 314 0.5× 150 0.3× 379 2.2× 145 0.9× 75 1.7k

Countries citing papers authored by Hideharu Abe

Since Specialization
Citations

This map shows the geographic impact of Hideharu Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideharu Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideharu Abe more than expected).

Fields of papers citing papers by Hideharu Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideharu Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideharu Abe. The network helps show where Hideharu Abe may publish in the future.

Co-authorship network of co-authors of Hideharu Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Hideharu Abe. A scholar is included among the top collaborators of Hideharu Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideharu Abe. Hideharu Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishimura, Kenji, Kensei Taguchi, Seiji Kishi, et al.. (2021). Dual disruption of eNOS and ApoE gene accelerates kidney fibrosis and senescence after injury. Biochemical and Biophysical Research Communications. 556. 142–148. 8 indexed citations
2.
Sakurai, Akiko, Hiroyuki Ono, Arisa Ochi, et al.. (2019). Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy. PLoS ONE. 14(5). e0216788–e0216788. 36 indexed citations
3.
Takakura, Hiromasa, Akihito Nakanishi, Hideharu Abe, et al.. (2018). A Case of Mucoepidermoid Carcinoma of the Nasopharynx. Practica Oto-Rhino-Laryngologica. 111(4). 235–241.
4.
5.
Tominaga, Tatsuya, Hideharu Abe, Naoshi Fukushima, et al.. (2018). An adjustment in BMP4 function represents a treatment for diabetic nephropathy and podocyte injury. Scientific Reports. 8(1). 13011–13011. 16 indexed citations
6.
Ono, Hiroyuki, Taichi Murakami, Akira Mima, et al.. (2017). Successful treatment of highly advanced immunoglobulin G4-related kidney disease presenting renal mass-like regions with end-stage kidney failure: a case study. BMC Nephrology. 18(1). 261–261. 4 indexed citations
7.
8.
Abe, Hideharu, et al.. (2012). A Case of Acute Calcific Tendinitis of the Longus Colli. Practica oto-rhino-laryngologica Suppl. 134(0). 84–87.
9.
Fushiki, Hiroaki, et al.. (2012). Surgical Management of Parapharyngeal Space Tumors: Our Experience. Practica oto-rhino-laryngologica Suppl. 134(0). 88–95. 1 indexed citations
10.
Abe, Hideharu, Tatsuya Tominaga, Takeshi Matsubara, et al.. (2012). Scleraxis Modulates Bone Morphogenetic Protein 4 (BMP4)-Smad1 Protein-Smooth Muscle α-Actin (SMA) Signal Transduction in Diabetic Nephropathy. Journal of Biological Chemistry. 287(24). 20430–20442. 24 indexed citations
11.
Abe, Hideharu, Hideo Shojaku, & Yukio Watanabe. (2011). Dental-Impression Material in Nasal Cavity. Practica Oto-Rhino-Laryngologica. 104(4). 261–265. 1 indexed citations
12.
Baba, Yasuhiko, Kouzou Fukuyama, Hideharu Abe, et al.. (2011). Effect of chronic kidney disease on excessive daytime sleepiness in Parkinson disease. European Journal of Neurology. 18(11). 1299–1303. 6 indexed citations
13.
Tominaga, Tatsuya, Hideharu Abe, Otoya Ueda, et al.. (2011). Activation of Bone Morphogenetic Protein 4 Signaling Leads to Glomerulosclerosis That Mimics Diabetic Nephropathy. Journal of Biological Chemistry. 286(22). 20109–20116. 46 indexed citations
14.
Kishi, Seiji, Hideharu Abe, Haruhiko Akiyama, et al.. (2011). SOX9 Protein Induces a Chondrogenic Phenotype of Mesangial Cells and Contributes to Advanced Diabetic Nephropathy. Journal of Biological Chemistry. 286(37). 32162–32169. 28 indexed citations
15.
Araoka, Toshikazu, Hiroya Takeoka, Keisuke Nishioka, et al.. (2009). Safety and efficacy of interferon-beta therapy for hemodialysis patient with HCV. Nihon Toseki Igakkai Zasshi. 42(5). 393–402. 3 indexed citations
16.
Kanamori, Hiroshi, Takeshi Matsubara, Akira Mima, et al.. (2007). Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy. Biochemical and Biophysical Research Communications. 360(4). 772–777. 140 indexed citations
17.
Matsubara, Takeshi, Hideharu Abe, Hidenori Arai, et al.. (2006). Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy. Laboratory Investigation. 86(4). 357–368. 64 indexed citations
18.
Abe, Hideharu, Takeshi Matsubara, Noriyuki Iehara, et al.. (2004). Type IV Collagen Is Transcriptionally Regulated by Smad1 under Advanced Glycation End Product (AGE) Stimulation. Journal of Biological Chemistry. 279(14). 14201–14206. 78 indexed citations
19.
Hirata, Michinori, Naoshi Fukushima, Kenichiro Kusano, et al.. (2001). A Vitamin D Analog Ameliorates Glomerular Injury on Rat Glomerulonephritis. American Journal Of Pathology. 158(5). 1733–1741. 115 indexed citations
20.
Harada, Mayumi, et al.. (1990). A Case of Sepsis Caused by Edwardsiella tarda Complicated Panophthalmitis and Pyogenic Spondylitis. Kansenshogaku zasshi. 64(5). 620–624. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marinka A.H. Bakker Breakdown of academic impact, for papers by Julia Lichtnekert Breakdown of academic impact, for papers by Santhosh V. Kumar Breakdown of academic impact, for papers by Murthy N. Darisipudi Breakdown of academic impact, for papers by Justin Chun Breakdown of academic impact, for papers by Ian R. Witherden Breakdown of academic impact, for papers by Jean‐Michel Goujon Breakdown of academic impact, for papers by Ko‐Jen Li Breakdown of academic impact, for papers by Jyaysi Desai Breakdown of academic impact, for papers by An‐Hang Yang
Rankless by CCL
2026